✦ LIBER ✦

Clinical and immunological evaluation of anti-apoptosis protein, survivin-derived peptide vaccine in phase I clinical study for patients with advanced or recurrent breast cancer

✍ Scribed by Tetsuhiro Tsuruma; Yuji Iwayama; Tosei Ohmura; Tadashi Katsuramaki; Fumitake Hata; Tomohisa Furuhata; Koji Yamaguchi; Yasutoshi Kimura; Toshihiko Torigoe; Nobuhiko Toyota; Atsuhito Yagihashi; Yoshihiko Hirohashi; Hiroko Asanuma; Kumiko Shimozawa; Minoru Okazaki; Yasuhiro Mizushima; Naohiro Nomura; Noriyuki Sato; Koichi Hirata

Book ID: 119905488
Publisher: BioMed Central
Year: 2008
Tongue: English
Weight: 636 KB
Volume: 6
Category: Article
ISSN: 1479-5876
DOI: 10.1186/1479-5876-6-24

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I clinical study of anti-apoptosis

Phase I clinical study of anti-apoptosis protein survivin-derived peptide vaccination for patients with advanced or recurrent urothelial cancer

✍ Ichiya Honma; Hiroshi Kitamura; Toshihiko Torigoe; Akari Takahashi; Toshiaki Tan 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 424 KB

Phase I clinical study of anti-apoptosis

Phase I clinical study of anti-apoptosis protein, survivin-derived peptide vaccine therapy for patients with advanced or recurrent colorectal cancer

✍ Tetsuhiro Tsuruma; Fumitake Hata; Toshihiko Torigoe; Tomohisa Furuhata; Satomi I 📂 Article 📅 2004 🏛 BioMed Central 🌐 English ⚖ 832 KB

Phase I clinical trial of survivin-deriv

Phase I clinical trial of survivin-derived peptide vaccine therapy for patients with advanced or recurrent oral cancer

✍ Akihiro Miyazaki; Junichi Kobayashi; Toshihiko Torigoe; Yoshihiko Hirohashi; Tak 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 363 KB

Immunogenic enhancement and clinical eff

Immunogenic enhancement and clinical effect by type-I interferon of anti-apoptotic protein, survivin-derived peptide vaccine, in advanced colorectal cancer patients

✍ Hidekazu Kameshima; Tetsuhiro Tsuruma; Toshihiko Torigoe; Akari Takahashi; Yoshi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 525 KB

Clinical and Immunologic Responses of HL

Clinical and Immunologic Responses of HLA-A3+ Breast Cancer Patients Vaccinated with the HER2/neu-Derived Peptide Vaccine, E75, in a Phase I/II Clinical Trial

✍ Ritesh Patil; Guy T. Clifton; Jarrod P. Holmes; Asna Amin; Mark G. Carmichael; J 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 728 KB